Cereno Scientific Targets EPIMODE Recruitment Completion in 2027

Cereno Scientific reported positive topline results from its CS014 Phase I PK bridging study. It continues to target EPIMODE recruitment completion during 2027, with topline results in Q4 2028, subject to recruitment progress.